Sergey Young
Founder @ Longevity Vision Fund
London, United Kingdom
Sergey Young is a debt financing investor at Longevity Vision Fund in London focused on Medical and Biotechnology. Sergey Young is based out of Abu Dhabi, Abu Dhabi Emirate and is the Founder of BOLD Longevity Growth Fund. Sergey previously worked at Family Office as a CEO. Sergey Young attended University of Warwick.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Sergey Young invests in
Stages Sergey Young invests in
Countries Sergey Young invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (50%)
- Biotechnology 1 (50%)
- Clinical Trials 1 (50%)
Stage
- Debt Financing 1 (50%)
- Convertible Note 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD). | $11M / Convertible Note / Dec 30, 2020 | ||
| LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD). | $4M / Debt Financing / Oct 21, 2019 |
Co-Investors
About Longevity Vision Fund
Longevity Vision Fund is a $100M investment fund dedicated to making longevity affordable and accessible to all. The fund accelerates longevity breakthroughs by investing in companies that develop technologies, products, and services that extend healthy human lifespans and overcome the negative effects of agingLongevity Vision Fund provides Seedto Series C funding to biotech and life extension-focused companies that have demonstrated affordable longevity potential and vision of milestones driving up the value of the company and market validation.
Longevity Vision Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Avik Arakelian
Head of Investments
|
|||
|
Sergey Young
Founder
|
|||
Sourav Sinha
Venture Partner & Head of Innovation
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Sergey Young invest in?
Sergey Young invests primarily in Medical, Biotechnology and Clinical Trials startups, most often at Debt Financing and Convertible Note stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Sergey Young?
Public channels for Sergey Young include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Sergey Young last invest?
The most recent investment recorded for Sergey Young closed in Dec 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
